Welcome to LookChem.com Sign In|Join Free

Home > Products > 676360-85-3

1,3,5-Triazine-2,4-diamine, N-(3-chloro-4-methoxyphenyl)-N'-cycloheptyl-6-(1-methylethoxy)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

676360-85-3

Post Buying Request

Basic information
1. Product Name: 1,3,5-Triazine-2,4-diamine, N-(3-chloro-4-methoxyphenyl)-N'-cycloheptyl-6-(1-methylethoxy)-
2. Synonyms:
3. CAS NO:676360-85-3
4. Molecular Formula: C20H28ClN5O2
5. Molecular Weight: 405.928
6. EINECS: N/A
7. Product Categories: N/A
Chemical Properties
1. Melting Point: N/A
2. Boiling Point: N/A
3. Flash Point: N/A
4. Appearance: N/A
5. Density: N/A
6. Refractive Index: N/A
7. Storage Temp.: N/A
8. Solubility: N/A
9. CAS DataBase Reference: 1,3,5-Triazine-2,4-diamine, N-(3-chloro-4-methoxyphenyl)-N'-cycloheptyl-6-(1-methylethoxy)-(CAS DataBase Reference)
10. NIST Chemistry Reference: 1,3,5-Triazine-2,4-diamine, N-(3-chloro-4-methoxyphenyl)-N'-cycloheptyl-6-(1-methylethoxy)-(676360-85-3)
11. EPA Substance Registry System: 1,3,5-Triazine-2,4-diamine, N-(3-chloro-4-methoxyphenyl)-N'-cycloheptyl-6-(1-methylethoxy)-(676360-85-3)
Safety Data
1. Hazard Codes: N/A
2. Statements: N/A
3. Safety Statements: N/A
4. WGK Germany:
5. RTECS:
6. HazardClass: N/A
7. PackingGroup: N/A
8. Hazardous Substances Data: 676360-85-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

676360-85-3 Suppliers

Recommended suppliers

676360-85-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 676360-85-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,3,6 and 0 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 676360-85:
(8*6)+(7*7)+(6*6)+(5*3)+(4*6)+(3*0)+(2*8)+(1*5)=193
193 % 10 = 3
So 676360-85-3 is a valid CAS Registry Number.

676360-85-3Upstream product

676360-85-3Downstream Products

676360-85-3Relevant academic research and scientific papers

Methods and compositions of novel triazine compounds

-

Page/Page column 109, (2010/02/08)

The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Methods and compositions of novel triazine compounds

-

Page/Page column 126, (2010/02/08)

The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Methods and compositions of novel triazine compounds

-

Page/Page column 124, (2010/02/08)

The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS

-

Page 378, (2010/11/30)

The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 676360-85-3

About us - Payment - Contact us - Links - Help Center - Disclaimer
SiteMap | Manufacturers | VIP Product | Suppliers | CAS | New CAS | Cas Database | Article Data | Chemical Catalog | Product Name

©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
[Hangzhou]86-0571-87562588,87562578,87562573 Our Legal adviser: Lawyer